Press
Biotech Professionals Express Fears…and Hope, During Pandemic
The fourth-most mentioned fear (at 14%) was a resurgence or a spike in infections after restrictions are lifted. Much about the SARS-CoV-2 virus is...
Clinical Trial Begins Using Sapphire Biotech’s Lateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer
Sapphire Biotech scientists have developed a new lateral flow assay test to measure the enzyme QSOX1 that is found to be elevated in subjects with...
Sapphire Biotech Files for Small Business Investigational Research Grant to Develop Compounds That Target Metastasis
Sapphire Biotech has filed for a Small Business Investigational Research (SBIR) grant to develop potent and soluble analogs of SBI-183, a compound...
Sapphire Biotech Files for Patent Protection and Tests 200 Bladder Cancer Patient Samples to Validate its Unique Biomarker to Detect Cancer
Sapphire began testing 200 bladder cancer patient samples to test for the presence of QSOX1-related biomarkers. Utilizing Sapphire’s proprietary...
Sapphire Biotech, Inc. is Formed to Develop Novel Therapeutic Approaches for the Treatment of Cancer Metastasis
Sapphire Biotech’s technology was formed for the purpose of developing novel therapeutic approaches for the treatment of cancer metastasis. Sapphire...